BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2006
View Archived Issues
DTA-H19: a new DNA-based cancer therapy
Read More
7TM Pharma receives milestone payment from research collaboration with P&G
Read More
BGC-20-761 improves in vivo cognitive benefits mediated via 5-HT6 antagonism
Read More
Spine Wave cleared to begin pilot trial of NuCore Injectable Nucleus
Read More
Rexahn partners with University of Maryland in nanomedicine
Read More
Nastech Pharmaceutical acquires RNAi program targeting influenza from Galenea
Read More
Targeting of IGF-IR and Bcl-2 eradicates androgen-independent prostate cells in vitro
Read More
mGluR III agonists: New restorers of neural circuits in Parkinson's disease?
Read More
Xanthus Life Sciences changes name to Xanthus Pharmaceuticals
Read More
Celtic Pharma licenses IDEA's Transfersome technology and derma pipeline
Read More
AP-5346 studied in head and neck cancer
Read More
Phase I study assesses safety of gene therapy product AGTC-0106
Read More
ZIO-201 begins phase I/II study in sarcoma
Read More
Alcon withdraws application to extend European approval of Opatanol
Read More
OrthoLogic to acquire certain assets of AzERx
Read More
Cyproxan receives Japanese approval for new indication
Read More
PEP-005 Topical gel well tolerated in dose-escalation study
Read More
In vivo metabolism of new combi-molecule facilitates potent multiple tumor targeting
Read More
Indole-3-carbinol and genistein target BRCA1 and BRCA2 genes
Read More
LA-12 overcomes cisplatin resistance in ovarian tumors in mice
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Recent patents disclose novel ophthalmic drugs
Read More
New melanocortin MC4 receptor ligands prepared and tested by SCRAS
Read More
Phase II trial assesses cortisol synthesis inhibitor DIO-902 for type 2 diabetes
Read More
European approval for Rotarix
Read More
Oracea filed for approval in U.K.
Read More
EluSys presents new efficacy data for Anthim anthrax therapeutic
Read More
Ampligen plus oseltamivir or zanamivir synergistically inhibits avian influenza
Read More
